Publication:
Tardive dystonia associated with olanzapine therapy

dc.contributor.authorsGunal, DI; Onultan, O; Afsar, N; Aktan, S
dc.date.accessioned2022-03-10T11:19:43Z
dc.date.accessioned2026-01-10T18:57:16Z
dc.date.available2022-03-10T11:19:43Z
dc.date.issued2001
dc.description.abstractA 21-year-old man with the diagnosis of paranoid schizophrenia was admitted to our clinic with cervical dystonia developing at the end of the first year of olanzapine therapy. The present case suggests that tardive dystonia in this patient is most likely associated with olanzapine administration as this is the main antipsychotic he received. Regarding the few case reports of olanzapine-associated tardive syndromes, patients taking olanzapine should be carefully screened for the appearance of tardive movements.
dc.identifier.doi10.1007/s10072-001-8177-4
dc.identifier.issn1590-1874
dc.identifier.pubmed11808858
dc.identifier.urihttps://hdl.handle.net/11424/219531
dc.identifier.wosWOS:000173311000009
dc.language.isoeng
dc.publisherSPRINGER-VERLAG
dc.relation.ispartofNEUROLOGICAL SCIENCES
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjecttardive dystonia
dc.subjectolanzapine
dc.subjectatypical
dc.subjectneuroleptic
dc.subjectDYSKINESIA
dc.titleTardive dystonia associated with olanzapine therapy
dc.typeeditorial
dspace.entity.typePublication
oaire.citation.endPage332
oaire.citation.issue4
oaire.citation.startPage331
oaire.citation.titleNEUROLOGICAL SCIENCES
oaire.citation.volume22

Files